Dr. Kieswetter currently serves as Senior Director, Innovation and Strategic Marketing at Acelity, a 3M company, where she is responsible for the Open Innovation organization. The team performs technology scouting and assessment for future products and provides technical and scientific support to other product development teams. During her twenty-plus year career she has been involved in both device and drug product development. Following a post-doctoral fellowship at the Center for the Bone-Biomaterial Interface at the University of Texas at San Antonio, she joined OsteoBiologics, Inc., a start- up firm dedicated to the development of biodegradable implants for cartilage and bone repair. She returned to the medical device arena following two years developing topical wound care products at Healthpoint, Ltd. While at KCI she established the Research organization and has also been responsible for the organization tasked to capture and develop ideas, and to assess and manage potential develop opportunities. In her unique leadership role for innovation and portfolio development, she has become a proponent of thoroughly understanding the related, yet often differing, needs of clinicians, patients, payors and internal customers on a global basis.

Kieswetter is a member of the Society for Biomaterials, Orthopaedic Research Society, Tissue Engineering Society International, and has served on the board of directors of the Wound Healing Society. She has received several patents, published in the fields of biomaterials, orthopaedics and wound healing and mentored two first place teams in the Free Trade Alliance’s International Business Plan competition. She holds Bachelor of Science degrees in Material Science and Engineering as well as Biomedical Engineering from Johns Hopkins University, a Master of Science and PhD from Case Western Reserve University and a MBA from the University of Texas (San Antonio). Dr. Kieswetter serves on the board of directors for The Health Cell